BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Kymera Therapeutics

Kymera Therapeutics logo

Founded
2017
Patents
34
Clinical Trials
4
Publications
12

Technologies

Protein Degraders Startups

Kymera Therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. We are advancing the field of targeted protein degradation, accessing the body’s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. Powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients.

Become a Member to view additional information about this company

Posts Mentioning This Company